HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidermolysis bullosa simplex with mottled pigmentation: clinical aspects and confirmation of the P24L mutation in the KRT5 gene in further patients.

Abstract
Epidermolysis bullosa simplex with mottled pigmentation (EBS-MP) is a rare dermatologic disorder of autosomal dominant inheritance with intraepidermal blistering after minor trauma, reticular hyperpigmentation unrelated to the blistering, nail dystrophy, and mild palmoplantar keratosis. Keratin 5 and keratin 14 are known to be essential for the basal keratinocyte cytoskeleton and are defective in several forms of epidermolysis bullosa simplex. Recently, a 71C-->T transition in the keratin 5 gene (KRT5) causing a P24L substitution was identified in some patients with EBS-MP. We present a family with three affected members and a sporadic patient with EBS-MP. They exemplify clinically mild expression with intrafamilial variability and the possibility of improvement with time. In all of them, mutation analysis of the KRT5 gene showed the P24L mutation. So far, other mutations in the same or in other genes have not been reported in patients with EBS-MP.
AuthorsU Moog, C E de Die-Smulders, H Scheffer, P van der Vlies, C J Henquet, M F Jonkman
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 86 Issue 4 Pg. 376-9 (Oct 08 1999) ISSN: 0148-7299 [Print] United States
PMID10494094 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 1999 Wiley-Liss, Inc.
Chemical References
  • Keratins
  • DNA
Topics
  • Adult
  • Base Sequence
  • Child
  • DNA (genetics)
  • DNA Mutational Analysis
  • Epidermis (ultrastructure)
  • Epidermolysis Bullosa Simplex (complications, genetics, pathology)
  • Female
  • Genes, Dominant
  • Humans
  • Hyperpigmentation (complications, genetics, pathology)
  • Infant
  • Keratins (genetics)
  • Male
  • Microscopy, Electron
  • Point Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: